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1. Introduction  
In this chapter, we will discuss the fate of nanoparticles when they are introduced into a 
system. Recent advances in synthesis and functionalization of nanoparticles have brought a 
significant increase in their biomedical applications, including imaging of cell and tissues, 
drug delivery, sensing of target molecules, etc. For example, iron oxide nanoparticles 
(Feridex) have been clinically administered as a contrast agent in magnetic resonance 
imaging (MRI).  
Their superb magnetic properties provide a significant contrast of tissues and cells where 
particles were administered. The use of Feridex as a MRI contrast agent enables a facile 
diagnosis of cancers in diverse organs in their early stages of development. As the range of 
different nanoparticles and their biomedical applications continue to expand, safety 
concerns over their use have been growing as well, leading to an increasing number of 
research on their in vivo toxicity, hazards, and biodistributions. 
While the number of studies assessing in vivo safety of nanoparticles has been increasing, a 
lack of understanding persists on the mechanisms of adverse effects and the distribution 
pathways. It is a challenge to correlate reports on one type of particles to reports on other 
types due to their intrinsic differences in the physical properties (particle size, shape, etc.) 
and chemical properties (surface chemistry, hydrophobicity, etc.), methods of preparation, 
and their biological targets (cells, tissues, organs, animals).  
Discrepancies in experimental conditions among different studies is currently bewildering 
the field, and there exists a critical need to arrive at a consensus on a gold standard of 
toxicity measure for probing in vivo fate of nanoparticles. This chapter summarizes recent 
studies on in vivo nanoparticle safety and biodistribution of nanoparticles in different 
organs. An emphasis is placed on a systematic categorization of reported findings from in 
vivo studies over particle types, sizes, shapes, surface functionalization, animal models, 
types of organs, toxicity assays, and distribution of particles in different organs.  
Based on our analysis of data and summary, we outline agreements and disagreements 
between studies on the fate of nanoparticles in vivo and we arrive at general conclusions on 
the current state and future direction of in vivo research on nanoparticle safety. 
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2. Nanoparticles in biomedical applications 
Particles in nanosize have significantly different characteristics from particles not in 
nanoscale. Since these nanoparticle properties are often in many applications, they have 
been applied in a wide variety of medical research. (Bystrzejewski, Cudzilo et al. 2007; Yu 
2008; Nune, Gunda et al. 2009; Yaghini, Seifalian et al. 2009)  
 
 
Fig. 1. Multifunctional nanoparticles in bioimaging and medicine. Developed synthesis and 
bioconjugation strategies for multifunctional nanoparticles helps enabling applications of 
multifunctional nanoparticles in in vivo imaging and therapy.  
In this chapter, nanoparticles of different kinds will be reviewed for their applications in 
biomedical imaging and therapeutics. Popular nanoparticles in biomolecular and 
biomedical imaging include fluorescent particles for optical imaging, such as quantum dots, 
gold nanoparticles and magnetic particles for MRI. Nanoparticle derives therapeutics 
includes heat ablation of target tumours, or delivery of drugs. Figure 1 summarizes the 
attributes of multifunctional nanoparticles that have attracted the field of bioimaging and 
medicine. Multiple modalities of these particles enable the accurate, less-invasive diagnosis 
and therapeutic approaches. 
2.1 Imaging 
Nanoparticles in imaging applications have been increasingly developed in last 20 years. 
Because of the superior photo stability, narrow range of emission, broad excitation 
wavelength, multiple possibilities of modification, quantum dots have gathered much 
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attention from engineering and scientists who are interested in bio markers, sensors or drug 
targeting. (Willard and Van Orden 2003; Qi and Gao 2008; Ghaderi, Ramesh et al. 2010; Han, 
Cui et al. 2010; Li, Wang et al. 2010) Commercially available binary quantum dots from Qdot 
have been successfully applied for above purposes during the last 10 years and reported in a 
vast number of literatures. Small size comparable to biomolecules (antibody, RNA, virus, 
etc.), high quantum yields and high magnetism are few representative advantages of 
nanoparticles that makes them to be a next generation imaging tools for in vivo imaging 
applications.  
2.1.1 Nanoparticles for optical imaging 
The most widely used nanoparticles in optical imaging are semiconductor nanocrystals, 
known as quantum dots. Their size dependent optical properties are unique in their 
applications to the efficient labelling of biomolecules and tissues where the traditional 
fluorescent labels have been hardly accessible to because of the size restrictions. In contrast, 
the size and shape of fluorescent nanoparticlces can be rather easily controllable during their 
synthesis. Semiconductor quantum dots are about 100 times brighter, have narrow emission 
spectra and broader excitation than traditional organic dye molecules. Since the quantum 
dots share the similar excitation wavelength and the emission is size tunable, multiple color 
imaging with single excitation. 
Recent developments of conjugating particle surface with biomolecules allowed cell targeting 
using quantum dots. (Hoshino, Hanaki et al. 2004; Jaiswal, Goldman et al. 2004) Targeting of 
cells with quantum dots, however, often faces the issues in their accessibility of internalization. 
Larger size particles will affect protein trafficking and the viability of the cells. 
Whether fluorescent nanoparticles are uptaken into the cell or not is critical decision maker 
in application of them for in vivo imaging. The number of nanoparticles in the cell cytoplasm 
should be to enough to enlighten the cell in the deep tissue. Although there have been 
efforts to enhance the fluorescent signal in the deep tissue by using a two-photon 
microscope or upconversion nanoparticles, it is still important to have enough number of 
nanoparticles per cell to be able to clearly visualize the target. A difficulty here is, the 
increased number of nanoparticles will increase toxicity of them to the cells. Therefore, the 
development of fluorescent nanoparticles for in vivo imaging is still an open challenge. 
In vivo imaging of the target cells by fluorescent nanoparticles are often achieved by first 
labeling cells with particles then injecting them in the target. Loading of nanoparticles into 
human cancer cells in vitro has been shown successfully (Sage 2004; Li, Wang et al. 2006; 
Xing, Smith et al. 2006) and their in vivo application in mice model (Kim, Jin et al. 2006; 
DeNardo, DeNardo et al. 2007; Goldberg, Xing et al. 2011) was evaluated as well. It showed 
the division of human cancer cells and their reforming of tumour tracked by fluorescence. In 
imaging of lymphatic or cardiovascular systems, fluorescent nanoparticles have shown their 
potentials. Sentinel lymph systems in small animals were imaged by using a near infrared 
emitting quantum dots. (Parungo, Colson et al. 2005; Soltesz, Kim et al. 2006; Frangioni, Kim 
et al. 2007) Trafficking of quantum dots in those lymphatic systems was rather investigated 
by other groups as well. Lymph node imaging is beneficial to the surgeons for them to 
locate the exact position of the target.  
Another example of in vivo imaging application using fluorescent nanoparticles is imaging 
of cardiovascular systems. Sensitivity and stability of fluorophore is always been a challenge 
in cardiovascular imaging. Coronary vasculature of a rat heart has been imaged with near IR 
emitting nanoparticles with high sensitivity. (Morgan, English et al. 2005)  
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Early detection of cancerous cells is the topic of interest for applications of quantum dots. 
Multiplexing of quantum dots for the better targeting and sensitivity has been a candidate 
for this purpose. Surface receptors are available on cancer cells that can be targeted by the 
multiplxed nanoparticles. Antibody coated quantum dots that are specific to the surface 
markers on cancer cells were demonstrated to label them in mice. Currently, targeting 
tumours are based on such an approach that functionalizing quantum dots with molecules 
specific to the target.  
Since in vivo imaging requires high quantum efficiency of quantum dots to penetrate deep 
tissue and organs, its bioconjugation strategy should also be compatible to keep the initial 
brightness. In that regards, near IR emitting quantum dots are believed to be the optimal 
candidates for in vivo optical imaging. Infrared has the long wavelength that it can penetrate 
the deep tissues relatively better than other visible lights. It will also minimize the possible 
false positive signal by autofluorescence from the background since near IR is not relatively 
absorbed well by water or hemoglobin in the system.  
Gold nanoparticles have been the popular choice for near IR emitting nano fluorophores 
since it is relative biocompatible and easy to synthesize. (Lee, Cha et al. 2008; Shang, Yin et 
al. 2009) The surface plasmon resonance is dependent on the size of the nanoparticles that it 
moves towards red with increasing particle size. Other types of gold nanomaterials such as 
gold nanorods and gold nanoshells were also popularly used in bioimaging because of its 
tunable surface plasmon bands and controllable position of the resonance by varying the 
synthesis conditions. 
Several imaging methodologies were developed to be able to use gold nanoparticles and 
their derivatives in bioimaging. Optical Coherence Tomography (OCT) uses the scattering 
function of gold nanoshells for in vivo imaging. (Agrawal, Huang et al. 2006; Adler, Huang 
et al. 2008; Skrabalak, Chen et al. 2008) The accumulation of gold nanoshells at the tumour 
increases scattering at that location that provides the contrast. Another imaging tool for gold 
nanomaterials is using photoacoustic imaging. The photoacustic imaging adapts a pulse of 
near IR that causes thermal expansion nearby and sound wave detectable at the surface. 
Distinctive sound wave generated by gold nanoparticles can be separated from background 
signal by surrounding tissues and organs.  
Another approach of adapting gold nanomaterials for in vivo imaging is using a two-photon 
fluorescence spectroscopy. Since gold nanomaterials possess the strong surface plasmon 
resonance, it can increase occurrence rate of two-photon excitation and relaxation of energy 
through fluorescence. 
Lastly, Raman spectroscopy can be used for enhanced Raman effect at the surface of gold 
nanomaterials. Location of gold nanoparticles in animal model was demonstrated by using 
a Raman effect of reporter dye on the gold surface of particles. (Christiansen, Becker et al. 
2007; Lu, Singh et al. 2010)  
Although quantum dots are useful as a tagging material, they also have several disadvantages. 
First and the most serious demerits of binary quantum dot is that it is toxic to cells. Most 
popular components of binary quantum dots are cadmium / serenide which are deleterious to 
cells. Because of the intrinsic toxicity of binary quantum dot, very thick surface coating is 
required. The final size of quantum dot is almost twice as thick as the initial core size and 
hinders the applications of quantum dots in a cell. Another drawback of binary quantum dot is 
its blinking behavior when a single binary quantum dot is observed with confocal fluorescent 
microscope. (Durisic, Bachir et al. 2007; Lee and Osborne 2009; Peterson and Nesbitt 2009) Its 
blinking behavior hinders the tracking of quantum dot targeted bio molecule in a bio system. 
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Because of drawbacks of binary quantum dots, silicon nanocrystal has been studied to 
overcome the demerits of commercially available quantum dots and be used as a 
substituting fluorophore with traditional organic dyes. Silicon nanocrystals’ superiorities as 
a fluorophore are summarized in Table 1. Silicon is basically non-toxic to cells so that it does 
not require a thick surface coating to prevent exposure of core to the environment. 
Therefore, its average size remains close to its core size. 
 
 
Table 1. Comparison of characteristic properties of Silicon nanocrystal with binary quantum 
dots and traditional organic dyes. 
2.1.2 Magnetic nanoparticles 
Recently, various non-invasive imaging methods have been developed by labeling stem 
cells using nanoparticles such as magnetic nanocrystals, quantum dots, and carbon 
nanotubes. Among these, magnetic nanocrystals provide the excellent probe for the 
magnetic resonance imaging (MRI), which is widely used imaging modality to present a 
high spatial resolution and great anatomical detail. 
In the last decade, superparamagnetic iron oxide (SPIO) nanoparticle has become the gold 
standard for MRI cell tracking, and has even entered clinical use. However, in many cases, 
SPIO-labeled cells producing hypointensities on T2/T2*-weighted MR images, cannot be 
distinguished from other hypointense regions such as blood clots or scar tissues in some 
experimental disease models. Moreover, the susceptibility artifact or “blooming effect” 
resulting from the high susceptibility of the SPIO may distort the background images. 
Gd complex based contrast agents can be good alternative MRI contrasts to generate the 
unambiguous positive contrast (hyper-intensity) and developed. Even if they produce 
positive contrast and increase the visibility of cells in low signal tissue, they have short 
residence time and can’t pass through the cell membrane easily. Therefore, there have been 
developed some of Gd ion based nanopaticulate contrast agents to overcome these 
disadvantages of the complex agents. (Ananta, Godin et al. 2010)  
MnO nanoparticles have also been recently explored as a new T1 MRI contrast agent and 
fine anatomical features of the mouse brain were successfully obtained. These MnO 
nanoparticles were also used to demonstrate feasibility of cell labeling and in vivo MRI 
tracking. (Baek, Park et al. 2010) However, under existing MnO based nanoparticle systems, 
the contrast is weak and the duration of signal is short for the long time in vivo MRI 
tracking. 
Therefore, it is required the further development of the MnO based contrast agent with high 
relaxivities and improved cellular uptake to stem cells which is more difficult to label due to 
the lack of substantial phgocytic capacity. (Kim, Momin et al. 2011) 
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2.2 Multifunctional nanoparticles in therapy 
Multifunctional nanoparticles are in the process of being evaluated as new tools for therapy 
in biomedical research. In the United States 15 out of every 100,000 persons are diagnosed 
with brain cancer every year.  
The most common type of adult brain tumor is malignant glioma with median survival rate 
of 10-12 month. Due to the complexity of the brain, the most practical treatment remained 
surgical removal of the tumor that frequently results in reoccurrence of the disease.  
A new type of nanoparticles is suggested that it cannot only be used for imaging but also 
can be used as a therapeutic agent. These new nanoparticles can be activated either by using 
radiofrequency (RF) pulses or infrared light to release the drug.  
2.2.1 Hyperthermia 
In order to implement hyperthermia treatment, magnetic nanoparticles can be introduced in 
the body through magnetic delivery systems (high gradient magnetic fields) or local 
injection to the affected area. (Corchero and Villaverde 2009)  
MRI utilizes RF pulses to generate coherent magnetization from the magnetic moments of 
water molecules in the sample that can then be detected. Since RF energy can also be 
converted into heat (e.g. similar to using a microwave to boil water) if the MRI agents can 
absorb RF energy efficiently, then a localized heating is possible during MR image 
collection. This idea of RF induced hyperthermia, or in other words, RF ablation has been 
studied in cancer research since the 1950’s.  
Certain parameters should be evaluated before deciding the contrast agent for the best 
hyperthermia applications. The best candidate nanoparticles are selected following these 
categories; specific absorption rate, size, biocompatibility. 
Tumor treatment by hyperthermia has limitations, however, that the most of nanoparticles 
do not have high specific absorption rate. At least 10% of tumor weight should be absorbed 
in order to be effective to heat-ablate tumors through hyperthermia.  
Treatment of malignant tumors at any site in the body is expected to be possible if agents 
that convert RF energy into heat can be delivered to the malignant cells. However, RF 
ablation suffers from the disadvantage that it is an invasive method that often requires 
insertion of electrodes into the body to deliver RF to the tumor sites.  
Superparamagnetic iron oxide nanoparticles of a correctly determined size are appropriate 
for in vivo hyperthermia applications, as they have no net magnetization without the 
external magnetic field. No net magnetization without the external magnetic field would 
eliminate the possible particle aggregation in the system. Aggregated particles often 
experience non-specific engulfment by reticular endothelial system that will significantly 
reduce the contrast. 
Plasmonic photothermal therapy is another new technology to treat tumor by using 
nanoparticles. (Chen, Frey et al. 2010) Plasmonic photothermal therapy is based on the 
surface plasmon resonance effect in nanoparticles when the light activates them. Most 
common example of this therapy is using gold nanoshells that we discussed before to 
achieve localised, irreversible thermal ablation of the tumor.  
In future direction of the research, the MRI will be used passively to visualize the tumor and 
actively to eradicate it. Multifunctional nanoparticles have a tremendous potential for RF 
activated heating and triggering since they possess magnetic properties to generate MRI 
contrast, have the ability to absorb remote RF energy, and can deliver/release anti-cancer 
drugs in a controlled manner.  
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2.2.2 Photodynamic therapy 
Singlet oxygen (1O2), as a part of reactive oxygen species (ROS) is useful tool to destruct 
cancer cells at the local site when singlet oxygen is concentrated. Photodynamic therapy is 
a new technology to treat tumor based on nanoparticle generated ROS at the tumor site. 
(Takahashi, Nagao et al. 2002; Oberdanner, Plaetzer et al. 2005) Photosensitizers, such as 
nanoparticles, can produce ROS when they are activated with the appropriate wavelength 
of excitation light. Nanoparticles as photosensitizers must be in close proximity to the 
tumor cells that they are usually administered at the tumor site directly. Photodynamic 
therapy is desirable in that it is relatively non-invasive and low toxicity. The major 
technical barrier, however, of this therapy is its difficulty in systemic introduction of 
photosensitizer to the tumor site and local irradiation to activate them. Tumors that have 
disseminated throughout the whole body may not be adequate for this therapy since the 
current technology is not available to irradiate the whole body. In addition, UV light is the 
wavelength of choice for the most of traditional photosensitizers that cannot efficiently 
penetrate into deep tissue. 
Therefore, the new class of nanoparticles called up-converting nanocrystals was introduced 
to alleviate these issues. (Vetrone, Naccache et al. 2010) Up-converting nanoparticles are 
excited by near infrared light that can efficiently penetrate tissues deeper than UV-VIS light, 
which allows for the non-invasive application of the method. Functionalized surface on up-
converting nanoparticles can direct particles to the specific tumor site that will concentrate 
ROS production.  
There are still few disadvantages of up-converting nanoparticles that their size is 
intrinsically large. The size of them is usually around 100 nm that may not be appropriate 
for in vivo imaging. Furthermore, ROS are produced at the surface shell of up-converting 
nanoparticles that its efficiency may be degraded while diffusing out to the surrounding 
environment. 
3. Toxicity 
Production and exposure of nanoparticles less than 100 nm in diameter may pose unknown 
risks since the responses of biological systems to novel materials of this size have not been 
adequately studied.  
The high surface area to volume ratio makes nanoparticles particularly good catalysts and 
such particles readily adhere to biological molecules. The size and surface charge of 
nanoparticles enable them to access places where larger particles may be blocked, including 
passage through cellular membranes. However, the wider application of semiconductor 
quantum dots as biological probes has been held back by their inherent chemical toxicity, 
which necessitates encapsulating them in a robust inert shell that increases the diameter of 
the probe.  
Although there are studies (Zhu, Oberdorster et al. 2006; Rogers, Franklin et al. 2007; 
Teeguarden, Hinderliter et al. 2007; Warheit, Hoke et al. 2007; Clift, Rothen-Rutishauser et 
al. 2008; Prow, Bhutto et al. 2008; Simon-Deckers, Gouget et al. 2008; Zhu, Zhu et al. 2008; 
Crosera, Bovenzi et al. 2009; Kramer, Bell et al. 2009; Marquis, Love et al. 2009; Monteiro-
Riviere, Inman et al. 2009; Simeonova and Erdely 2009; Warheit, Reed et al. 2009; DeVoll 
2010; Li, Muralikrishnan et al. 2010; Maurer-Jones, Lin et al. 2010; Samberg, Oldenburg et al. 
2010; Yang, Liu et al. 2010; Zhu, Chang et al. 2010) on both known and unknown hazards of 
several kinds of nanoparticles, many questions remain unanswered. Furthermore, there are 
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few systematic studies dealing with both cytotoxicity and inflammatory responses of cells 
treated with nanoparticles.  
How will a biological system react when exposed to nanoparticles? What is the fate of the 
nanoparticles once they are presented to a population of cells? If the nanoparticles enter into 
the cell, what effects do they exert internally? These questions must be answered in order to 
ensure safety to the patient if nanoparticles are incorporated in biomedical applications. 
In this chapter, we will discuss nanoparticles as for any diagnostic or medicinal tool and 
point out that nanoparticles can only be applicable to in vivo applications on humans when 
they pass the assessment for their toxicity. To the fact that the number of different 
nanomaterials synthesized and potentially targeted for in vivo applications is much more 
than the number of toxicity assessment for them, these investigations are only at the very 
early stage.  
Noticeable conclusions from those studies have been already distress the field and public to 
strengthen the extended investigation requirement before pursuing any further research. 
Recent reviews on the toxicity assessment of nanoparticles keep pointing out that the 
experimental conditions, preparations of nanoparticles and protocols the investigators use 
all affect the results. These discrepancies between studies even for the same kind of 
nanoparticle result from the complexity of the investigated systems and potential 
interference of nanomaterials to the assay techniques.  
3.1 Nanoparticle toxicity assessment in in vitro assays 
Growing public concern regarding the unknown toxicological effects of nanoparticles has 
spawned cooperative efforts by government agencies and academia to closely investigate 
these issues.  
 
In vitro assay Assay mechanism Detection Tested nanoparticles Pros Cons 
MTT (or MTS) Dead cells cannot 
reduce MTT (MTS).  
Absorption  Quantum dots, gold 
nanoparticles  
Widely used, 
relatively simple, 
low cost 
Metabolic activity can 
be affected by 
multiplexed effects 
Calcein AM Dead cells cannot 
cleave the 
acetomethoxy group 
of calcein AM  
Fluorescence Gold nanoshells  Widely used 
fluorescence assay, 
relatively simple, 
low cost 
Fluorescent 
nanoparticles 
interfere with calcein 
dyes. 
Protease 
activity assays 
(e.g., CytoTox-
Glo) 
Substrates bind to 
dead cells’ proteases 
in the media to 
produce a 
fluorescence signal. 
ELISA/fluoresc
ence 
colorimeter 
Fullerene, carbon 
black, quantum dots  
Cytotoxicity can be 
probed based on 
the activity of 
various proteases  
Expensive; 
fluorescent 
nanoparticles in the 
cell interfere with the 
signal. 
Blood contact 
properties (e.g., 
hemolysis) 
Hemoglobin released 
from cells is oxidized 
and quantified by its 
absorbance 
ELISA/ 
absorption 
colorimeter 
PAMAM dendrimers, 
TiO2 nanoparticles  
Widely used, 
relatively simple, 
low cost 
No established 
positive control for 
nanomaterials; 
possible interference 
Macrophage 
functions 
(cytokine 
induction) 
Nitric oxides, various 
cytokines (e.g., 
interleukins, TNF-
alpha) are induced 
ELISA/absorpti
on/fluorescenc
e colorimeter 
Si nanoparticles Widely used
fluorescence assay, 
relatively simple, 
low cost 
Fluorescent 
nanoparticles 
interfere with 
detection dyes 	  
Table 2. Summary of popular cytotoxicity and inflammatory response assays used for 
nanoparticles 
Nanoparticles may not be filtered by the body’s defense mechanisms because of their small 
size, which suggests that they may cause inflammatory and/or toxic responses. The 
reported cytotoxicity and immune response studies on nanoparticles have been based 
mainly on in vitro assays such as cell viability tests, cytokine release analyses and cell 
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function degradation analyses upon the exposure of a bulk culture of cells to nanoparticles 
(see available assays: http://ncl.cancer.gov/working_assay-cascade.asp).  
However, no validated standard or protocol has yet been established to test biological 
responses to nanoparticles. Table 2 lists a representative selection of cytotoxicity and 
inflammatory response assays used to test biological responses to nanoparticles. 
3.1.1 Nanotoxicity: Complex system to investigate 
The number of reports on assessment of the nanoparticle toxicity has been growing with the 
number of biomedical research associated with them. It is noticeable that the reports are not 
consistent in terms of particles’ toxicity results. Some reports on popular nanoparticles such 
as cadmium selenide, iron oxide, gold and silica nanoparticles all have non-consistent 
conclusions about their toxicity to the biological system. These inconsistent conclusions 
result from the fact that there is currently no standard protocol for the assessment of the 
toxicity of nanomaterials. Variation of experiment parameters as well as interference of 
nanoparticles to the measuring instruments is prime reasons that make it impossible to 
compare the results between different studies.  
3.1.2 Cytotoxicity  
The cytotoxicity of a nanomaterial is influenced by the following parameters: cell line, 
culture conditions for in vitro studies, how to introduce particles in in vivo studies, 
nanoparticle concentration, size and duration of exposure. No standard protocol is available 
at the current stage in terms of setting those parameters relatively be consistent. It is 
challenging, furthermore, to decide whether the reported range of particle concentration is 
physiologically relevant to the in vivo system.  
The cell line to test in vitro is a critical factor determining the degree of cytotoxicity of 
nanomaterials. In one study, nanoparticle uptake rate and resulted cytotoxicity was compared 
in the same cell line but prepared by following different protocols. It was found that the 
cytotoxicity could be varied among the cell lines depending on how they were prepared.  
Another factor for observed discrepancies between the results of toxicity assays is different 
testing methods applied on the same nanomaterial. 
In most of the in vitro cytotoxicity studies, cell death is investigated using colorimetric 
assays such as shift of absorption or emission of markers. For example, Trypan blue dye 
exclusion assay provides information of cell death by showing dye staining on cells that 
were ruptured. Potential issue here is that nanoparticles applied are usually strongly emit or 
absorb light. Nanoparticles absorb or emit light may give false positive signal.  
Cytotoxicity assays commonly used are to measure the effect of test compound that can 
rather quickly diffuse into the target cell that they can be assayed within the time frame 
when the dye still can be effective. Therefore, cytotoxicity assays are rarely run for over few 
days. Another potential issue here is that nanoparticles are less mobile than the most 
chemical compounds resulting that they will require longer duration of assays. This would 
require the modification of the cytotoxicity protocols that should be used for nanoparticles 
and nanomaterials.  
Physical and chemical characterizations of nanoparticles are critically important for 
cytotoxicity assays. For size analysis, either dynamic light scattering (DLS) or transmission 
electron microscopy (TEM) is the method of choice for the most of nanoparticles. The 
nanoparticles that are well dispersed in water would not show a significant aggregation or 
morphological variations in TEM images.  
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However, it is often pointed out in many studies that there are some discrepancies in mean 
particle size between that measured by TEM or by DLS. (Teeguarden, Hinderliter et al. 2007; 
Warheit, Hoke et al. 2007; Marquis, Love et al. 2009; Monteiro-Riviere, Inman et al. 2009; 
Vippola, Falck et al. 2009) These discrepancies may be due to differences in both preparation 
and the inherent limitations of nanoparticle sizing methods, and emphasize the necessity to 
apply multiple techniques for determining particle sizes in polydisperse batches. While 
TEM can serve as a tool to capture the size of each individual particle, it is limited in that it 
can only measure particles after they have been suspended and then dried, it requires 
measurements of many different particle regions to appropriately represent the entire 
particle batch, and complex geometries of particles or agglomerates may make 
characterization difficult. The solvent used to disperse the particles prior to drying for TEM 
analysis may also affect the measurements.  
While dynamic light scattering is performed in solutions, the suspending media and how 
the particle sample was mixed (i.e. sonication intensity and exposure time) and pre-filtered 
can significantly affect the particle hydrodynamic size analysis. Moreover, particle 
agglomeration and time-dependent sedimentation of large (i.e. > 100 nm) and dense silver 
particles may affect the DLS measurement reliability even during the short measurement 
time period (2-5 min).  
DLS measurements of highly polydispersed particle solutions are also dependent on the main 
analysis parameter. In an intensity-based DLS analysis of a polydisperse particle sample, 
smaller particles are under-represented due to weaker light scattering and particle shape 
effects. For this reason, a number-based DLS analysis would be more appropriate to highlight 
the most abundant particle size population so that one could make limited comparisons 
between the different particles, especially when the particles are not pre-filtered and the effect 
of media on nanoparticle size, agglomeration, and polydispersity are significant.  
In general, all of the aqueous particles demonstrate an increase in particle size and/or 
agglomeration, either by DLS measurement or visually, when mixed with DPBS media due to 
reaction with chloride ions and the presumable formation of poorly soluble silver chloride.  
Surface chemistry of nanoparticles is also another important factor that will affect 
cytotoxicity of nanoparticles. Citrate is the conjugate base of citric acid, which is a popular 
reducing agent used in silver and gold production, and provides a negatively charged 
surface moiety that stabilizes nanoparticle colloids through Columbic repulsion. The citrate-
stabilized nanoparticles suspended in water acquired a significant negative charge and 
acidified the aqueous solution.  
However, in comparing the nano-sized particles, it was found that particles share the similar 
pH and zeta potentials when they are diluted in PBS solution regardless of the degree of 
citrate coating on each particle. Furthermore, no significant differences in cytotoxicity levels 
between the nano-sized particles argues in favor of particle size as a stronger determinant of 
toxicity rather than initial surface chemical properties. This also emphasizes the potential 
importance of plasma proteins in altering the surface properties of nanoparticles by coating 
them and affecting their biocompatibility. 
3.2 Nanoparticle toxicity analysis toward its in vivo applications  
In general, the smaller the nanoparticle is the greater the toxicity. This is due in part to the 
fact that small nanoparticles are more readily uptaken into the cell or even near the nucleus. 
Larger nanoparticles may therefore be less cytotoxic simply because their cellular uptake is 
limited at that same concentration.  
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In order to consider and predict possible nanoparticles toxicity in in vivo applications, few 
things should be carefully examined. 
First of all, in vitro studies for cytotoxicity should carefully be used to extrapolate expected 
results in in vivo studies. Nanoparticles in in vivo system would experience much more 
complicated perturbations because of a wide variety of proteins and small biomolecules 
present around them. Because of these neighboring biomolecules, nanoparticles can be 
degraded, engulfed by phagocytic cells, or traveled away from the target site by lymphatic 
system. Assay responses obtained from well-controlled environment such as in culturing 
plate may not always present the same results obtained in in vivo environment. Therefore, it 
will be inadequate to draw any conclusions from the in vitro assay for nanoparticle 
responses in in vivo system until following experiments at least in animal model is 
performed. 
Second of all, limitations of current assays performed for cytotoxicity or inflammatory 
responses of cells to the nanomaterials should be carefully recognized and further 
endeavors to advance technologies for better assaying nanoparticles should be invested. 
Studies of in vitro cytotoxicity and the inflammatory response to nanoparticles have adopted 
conventional assays developed for chemical toxins or microparticles. These reports provide 
little insight into how individual cells react when exposed to nanoparticles. Also, the 
analysis of these assay results is prone to error because cells can behave differently 
depending on the assays employed.  
The limitations of current cytotoxicity and immune response assays for the assessment of 
nanoparticles can be summarized as follows. First, cells cannot be recovered after the single 
assay readout; thus the possibilities for time-dependent monitoring of changes in a cell’s 
activity are limited. Second, the assays’ readings are averaged over all the cells present. 
Therefore, a single cell’s responses to the nanoparticles cannot be individually recorded 
from the assay. Third, nanoparticles inside a cell may interfere with the fluorescence signal 
produced by the dye used in the assay. Additionally, nanoparticles may interact with 
and/or bind to dyes, altering their absorption and/or fluorescence. Nanoparticles can also 
adsorb to proteins and other biomolecules in the cell culture medium, which can interfere 
with the particles’ normal interactions with cells. Furthermore, nanoparticles can bind to 
cytokines released from the cells; this may artificially reduce an assay’s positive signal. Flow 
cytometry is a commonly used method in biological response assays, but the technique 
requires that cells be detached from the cell culture plate, which may alter the cells’ 
mortality. Finally, multiplexed analyses of nanoparticles in the same well with single cells 
have not been performed. Because of these limitations, there is an emergent need to develop 
a solid assay that overcomes the above-mentioned problems with conventional assays and is 
able to evaluate biological responses to nanoparticles in a multiplexed, high-throughput 
manner. 
Cutting-edge single-cell assay techniques have been developed for assessing cytotoxic and 
inflammatory responses to nanoparticles in a multiplexed manner. The multiplexed analysis 
strategy will be used in safety studies of various nanoparticles. Time-dependent analysis of 
a single cell’s responses to nanoparticles may elucidate the mechanism of toxicity for nano-
sized particles. Such single-cell analyses will be used in concert with conventional bulk 
assays. The approaches discussed will benefit nanotoxicological studies and help the 
broader nanotechnology community by providing proof of concept for an efficient analytical 
tool with which to investigate the safety of nanoparticles at the single-cell level in a high-
throughput and multiplexed fashion. 
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Fig. 2. Safety concerns about nanoparticles in in vivo applications grows and it is still a 
“black box” that has not been clearly shown its potential hazards.  
4. Conclusion 
The toxicity of nanoparticle is critically important topic for researchers both in material 
science and biomedical fields. Toxicity assessment so far has been informative but it could 
not catch up the development of technology especially in biological application of 
nanoparticlces as covered in earlier sections in this chapter. Even in in vitro assays, assay 
results were often challenged by their inconsistencies. For in vivo application it is even more 
important to have well defined, consistent assay protocol and techniques so that one can try 
to discover the key to the unknown, “black box” of particle toxicity in vivo (Figure 2). The 
immediate need in this regard will be the standardization of assessment protocols for 
nanoparticle toxicity. Government, academics and worldwide cooperation are desirable to 
facilitate this process for standardization of assays. In vitro findings should be carefully 
integrated to the in vivo behavior of nanoparticles since it is fairly different environment that 
nanoparticles will experience. For in vivo applications, therefore, extra care should be taken 
in prediction of potential toxicity of nanoparticles before their actual implementation.  
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